Bridgeport, CT – A Massachusetts man was sentenced to seven years in federal prison Friday for trafficking fentanyl and cocaine while on supervised release from a prior heroin conviction, prosecutors said.
Yoanni Suarez, 48, also known as “Cuba,” of Springfield, received 84 months of imprisonment and four years of supervised release from U.S. District Judge Stefan R. Underhill. Suarez had previously served more than six years for heroin trafficking before his release in April 2021.
According to court records, federal agents began investigating a large-scale drug network in July 2022 that was distributing kilogram quantities of fentanyl and cocaine across Connecticut. The probe, led by the DEA’s Hartford Task Force, used wiretaps, surveillance, and controlled purchases to track shipments moving from California through Mexico.
Investigators found Suarez helped coordinate shipments of fentanyl and cocaine into Connecticut, arranged local sales, and assisted in sending drug proceeds back to suppliers. His son, Giovanny Jorrin, was also implicated, mailing packages of cash to California, including one containing more than $38,000. Jorrin was sentenced to two years in prison in June.
Suarez pleaded guilty on June 13, 2023, to conspiracy to distribute and to possess with intent to distribute 40 grams or more of fentanyl. He has been in custody since his arrest a week earlier.
The case was prosecuted by Assistant U.S. Attorneys Robert S. Dearington and A. Reed Durham and investigated by the DEA’s Hartford Task Force, the FBI, and the U.S. Postal Inspection Service, with support from state and local police agencies. It was brought as part of the federal Organized Crime Drug Enforcement Task Forces (OCDETF) Program.
Key Points
- Yoanni Suarez, 48, sentenced to 84 months for fentanyl and cocaine trafficking.
- Suarez committed the crimes while on supervised release from a prior heroin case.
- His son, Giovanny Jorrin, was sentenced to two years for mailing drug proceeds.
Prosecutors said the sentence reflects Suarez’s role in fueling Connecticut’s drug trade while already under federal supervision.